Phase 1 Study Testing the Combination of Aflibercept and Capecitabine in Metastatic Digestive and Breast Cancers
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Colorectal Cancers|Metastatic Gastric Cancers|Metastatic Oesophageal Cancers|Metastatic Pancreatic Cancers|Metastatic Biliary Cancers|Metastatic Breast Cancers
Interventions: DRUG: capecitabine|DRUG: aflibercept|DRUG: Capecitabine
Sponsor: Jules Bordet Institute